[Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
Søndergaard
Bo
B
Medicinsk Gastroenterologisk Afdeling M1, Amtssygehuset i Glostrup.
Bytzer
Peter
P
D000863:Antacids / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology; D055502:Secondary Prevention
D000863:Antacids; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents